Company Filing History:
Years Active: 2022
Title: The Innovations of Hideaki Funami
Introduction
Hideaki Funami is a notable inventor based in Setagaya-ku, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on EP300 and CREBBP inhibitors. His research has the potential to impact various therapeutic areas.
Latest Patents
One of Funami's key patents is focused on an EP300/CREBBP inhibitor. This invention provides a compound that exhibits excellent histone acetyl transferase inhibitory activity against EP300 and/or CREBBP. The compound is represented by a specific formula or a pharmacologically acceptable salt thereof. This patent highlights his commitment to advancing medical science through innovative solutions.
Career Highlights
Funami is associated with Daiichi Sankyo Company, Limited, a prominent player in the pharmaceutical industry. His work at this company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Hiroyuki Naito and Yoshiko Kagoshima. Their collaborative efforts have likely enhanced the quality and impact of their research projects.
Conclusion
Hideaki Funami's contributions to the field of pharmacology through his innovative patents demonstrate his dedication to advancing medical science. His work continues to inspire future innovations in the industry.